Comparison of Sedation by Esketamine and Sevoflurane

Sponsor
Eye & ENT Hospital of Fudan University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05011214
Collaborator
(none)
60
1
2
7
8.6

Study Details

Study Description

Brief Summary

Pediatric diseases,including congenital cataract,,corneal injury,corneal ulcer, usually need suture removal and ophthalmic examination after Surgery for several days. Unfortunately, it remains a great challenge to achieve successful sedation due to children's noncooperation. Sevoflurane is one of the most often used anesthesia agents to provide deep sedation. Although sevoflurane has been used for pediatric anesthesia with successful keep spontaneous breathing without intubation, it should be noted that sevoflurane often results in air pollution under the open airway background and postoperative agitation.

Esketamine is the S (+) isomer of ketamine, which produces a dissociated state with minimal risk of airway compromise or apnea. It has enhanced analgesic potency and faster elimination compared to ketamine. However, it may also cause delirium during the recovery time. Based on these experiences on ketamine, we compared the effectiveness of esketamine and sevoflurane for short ophthalmological procedure in pediatric patients.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Pediatric diseases,including congenital cataract,,corneal injury,corneal ulcer, usually need suture removal and ophthalmic examination after Surgery for several days. Unfortunately, it remains a great challenge to achieve successful sedation to avoid body movement and keep perfect eye position due to children's noncooperation. Thus, appropriate sedative agents therefore need to be administrated to perform this minor surgery. Sevoflurane is used frequently inhalational anaesthetic agent to provide pediatric anaesthesia because of the nonirritant nature. It has been used for successful keeping spontaneous breathing without tracheal intubation. It should be noted that sevoflurane often results in air pollution under the open airway background and emergence agitation. High concentrations of sevoflurane may causes respiratory depression due to the decrease in tidal volume during spontaneous ventilation.

Ketamine is widely used for procedural sedation, which produces a dissociated state with minimal risk of airway compromise or apnea. Esketamine is the S (+) isomer of ketamine, It has enhanced analgesic potency and faster elimination compared to ketamine. However, it may also cause agitation during the recovery time. Based on these experiences on ketamine, we compared the effectiveness of esketamine and sevoflurane for short ophthalmological procedure in pediatric patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Comparison of Sedation by Esketamine and Sevoflurane for Short Ophthalmological Procedure in Children
Actual Study Start Date :
Sep 20, 2021
Actual Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Apr 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: group S

patients were anesthetized by face mask with 5 vol% sevoflurane with total 5 L/min-1 fresh gas flow. Anaesthesia was maintained by continuously using 3-4% sevoflurane.

Drug: Sevoflurane
All patients received 0.01 mg/kg atropine and 1ug/kg dexmedetomidine iv as premedication.5% sevoflurane(FIO2=100%, 3L·min-1) was used to induce anaesthesia by mask inhalation and 3-4 % sevoflurane (adjusted according to the depth of the anaesthesia,FIO2=100%, 2L·min-1) was maintained
Other Names:
  • Sevoflurane Inhalation Solution
  • Experimental: group E

    patients received 0.5mg/kg IV esketamine at first, after surgical field disinfection, another 0.25mg/kg IV esketamine was administered. Then 1mg/kg propofol was administered every 5 minutes after intubation.

    Drug: Esketamine
    All patients received 0.1 mg/kg atropine and 1ug/kg dexmedetomidine iv as premedication.0.5mg·kg-1 esketamine was administered by vein in one minute, and 0.25mg·kg-1 esketamine was given at the beginning of the surgery.
    Other Names:
  • s(+)ketamine
  • Outcome Measures

    Primary Outcome Measures

    1. eye position scale [during the surgery]

      1=The inner and outer canthus line across the central cornea; 2= Inferior limbus does not exceed the inner and outer canthus line; 3= Inferior limbus exceed the inner and outer canthus line.

    Secondary Outcome Measures

    1. the incidence of respiratory depression [during the surgery]

      decreased tidal volume or weak chest undulation

    2. the incidence of desaturation [during the surgery]

      the incidence of oxygen saturation below 95% caused by anesthetic agents

    3. Intraocular pressure [the time after intubation and topical anesthesia within 1 minute]

      Intraocular pressure after induction

    4. requirements for additional propofol [during the surgery]

      If the target level of sedation was not achieved, an additional 0.1mg/kg propofol was injected and repeated if necessary

    5. CPS score [scores at the time point of 1 minutes after extubation]

      The Cole 5-point scale (CPS) score included five behaviors: 1=sleeping; 1=awake,calm;3=irritable, crying;4=inconsolable crying; 5=severe restlessness, disorientation.

    6. length of stay in the post-anesthesia care unit [duration from the time patients arrived the post-anesthesia care unit to the time of leaving to the ward, average 20 mins]

      the time of the length of stay in the post-anesthesia care unit

    7. Mean blood pressure pressure [1minutes before induction;1minutes after induction;1minutes before intubation;1minutes after intubation,3 minutes after intubation]

      mean blood pressure

    8. Heart rate [1minutes before induction;1minutes after induction;1minutes before extubation;1minutes after extubation,3 minutes after extubation]

      Heart rate

    9. extubation time [duration from the time that patients arrived in post-anesthesia care unit to the time of extubation, average 10 mins]

      extubation time

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Months to 6 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patient who needed suture removal and ophthalmic examination
    Exclusion Criteria:
    • previous coronary heart disease,hypertension, arterial aneurysm, epilepsia, intracranial mass of benign or malign nature

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University Shanghai Shanghai China 200031

    Sponsors and Collaborators

    • Eye & ENT Hospital of Fudan University

    Investigators

    • Principal Investigator: Fang Tan, Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Eye & ENT Hospital of Fudan University
    ClinicalTrials.gov Identifier:
    NCT05011214
    Other Study ID Numbers:
    • esketamine
    First Posted:
    Aug 18, 2021
    Last Update Posted:
    Apr 5, 2022
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Eye & ENT Hospital of Fudan University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2022